id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-P-7054-0006,FDA,FDA-2025-P-7054,"Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T17:15:35Z,2026-09011,0,0,09000064b92c66bf
FDA-2025-P-7054-0007,FDA,FDA-2025-P-7054,"Response Letter from FDA CDER to Unichem Pharmaceuticals (USA), Inc.",Other,Letter(s),2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T21:33:35Z,,0,0,09000064b92c7e5d
FDA-2025-P-7054-0004,FDA,FDA-2025-P-7054,"Attachment 1 - Copies of relevant pages of Orange Book 45th Edition Cumulative Supplement 10, October 2025",Supporting & Related Material,Background Material,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T23:41:42Z,,0,0,09000064b90d40f4
FDA-2025-P-7054-0001,FDA,FDA-2025-P-7054,"Citizen Petition from Unichem Pharmaceuticals (USA), Inc.",Other,Citizen Petition,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,,2025-12-15T23:41:19Z,,1,0,09000064b90d0b3d
FDA-2025-P-7054-0002,FDA,FDA-2025-P-7054,"Acknowledgment Letter from FDA DMB to Unichem Pharmaceuticals (USA), Inc.",Other,Acknowledgement Letter/Receipt,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,,2025-12-15T23:41:31Z,,0,0,09000064b90d0b43
FDA-2025-P-7054-0003,FDA,FDA-2025-P-7054,Telmisartan Agency Response Nov 28 2025 (1),Supporting & Related Material,Background Material,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T23:41:39Z,,0,0,09000064b90d40f3
FDA-2025-P-7054-0005,FDA,FDA-2025-P-7054,"Attachment 2 - Copies of relevant pages of current Orange Book for approved generic applications of Telmisartan Tablets, 20 mg and 80 mg.",Supporting & Related Material,Background Material,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T23:41:46Z,,0,0,09000064b90d40f5